论文部分内容阅读
目的:观察中西医结合疗法对慢性溃疡性结肠炎(UC)的临床疗效。方法:将95例UC患者随机分为治疗组49例和对照组46例。对照组口服美沙拉嗪肠溶片,治疗组加用肠炎Ⅰ号方内服和结肠宁灌肠剂灌肠。疗程12周。观察临床症状、体征积分、肠镜检查和检测白细胞介素-1β(IL-1β),白细胞介素-4(IL-4)。结果:治疗组有效率95.9%优于对照组的76.1%(P<0.05);治疗组临床症状、体征总积分[(4.83±2.85)]低于对照组[(9.27±3.16)](P<0.01);治疗组肠镜检查溃疡、糜烂、出血点的改善优于对照组(P<0.01);治疗组IL-1β[(13.37±10.15)ng.L-1]低于对照组[(19.49±14.51)ng.L-1],IL-4[(17.26±3.82)ng.L-1]高于对照组[(13.22±3.43)ng.L-1](P<0.01)。结论:中西结合治疗慢性溃疡性结肠炎较单纯西药有明显的临床优势。
Objective: To observe the clinical efficacy of integrated traditional Chinese and western medicine on chronic ulcerative colitis (UC). Methods: Ninety-five patients with UC were randomly divided into treatment group (n = 49) and control group (n = 46). The control group oral mesalazine enteric-coated tablets, the treatment group plus enteritis Ⅰ oral and colon enema enema enema. Treatment for 12 weeks. Clinical symptoms, signs and scores, colonoscopy and detection of interleukin-1β (IL-1β) and interleukin-4 (IL-4) were observed. Results: The effective rate of treatment group was 95.9%, which was significantly lower than that of control group (76.1%, P <0.05). The total score of clinical symptoms and signs in treatment group [(4.83 ± 2.85)] was lower than that in control group [(9.27 ± 3.16) 0.01). The improvement of ulceration, erosion and bleeding in colonoscopy group was better than that of control group (P <0.01). The level of IL-1β in the treatment group was lower than that in the control group [(19.49 IL-4 [(17.26 ± 3.82) ng.L-1] was significantly higher than that of the control group [(13.22 ± 3.43) ng.L -1] (P <0.01 ± 14.51) ng.L -1. Conclusion: The treatment of chronic ulcerative colitis with traditional Chinese and western medicine has obvious clinical advantages over western medicine alone.